
September 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, AstraZeneca, Cancer, Iraw, J&J, JJ, Pfizer, Roche, UK, brexit, drug safety, pharma, pharmacovigilance

August 31, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Eisai, Medicare, Novartis, UK, brexit, generics, king bio, pharma, top ten
August 31, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

August 31, 2018 Medical Communications, Research and Development AstraZeneca, Lupus, anifrolumab, pharma
August 30, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, bristol myers squibb, cco, chief commercial officer, christopher boerner, executive vice president, murdo gordon

August 30, 2018 Research and Development MS, brain, ibudilast, neuroscience, research

August 30, 2018 Research and Development CBD, King's College London, Kings College London, Marijuana, psychosis, study

August 30, 2018 Research and Development, Sales and Marketing AstraZeneca, Bydureon, EU, Europe, diabetes, pharma, type 2 diabetes

August 29, 2018 Research and Development, Sales and Marketing Vyxeos, acute myeloid leukaemia, jazz pharmaceuticals, leukaemia, pharma

August 29, 2018 Research and Development, Sales and Marketing Emergent, Narcan, naloxone, opioid crisis, opioids, pharma

August 29, 2018 Research and Development England, GP, NHS, guidance, psychology, psychotherapy

August 29, 2018 Research and Development Contamination, FDA, homeopathy, king bio, recall

August 29, 2018 Research and Development CAR T, CAR-T, Jobs, Kymriah, Novartis

August 28, 2018 Manufacturing and Production, Research and Development, Sales and Marketing Eisai, lorcaserin, safety, study, weight loss

August 28, 2018 Manufacturing and Production, Research and Development, Sales and Marketing addiction, candidates, drug, nicotine, research, washington state university